1. Home
  2. SHLS vs NBTX Comparison

SHLS vs NBTX Comparison

Compare SHLS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shoals Technologies Group Inc.

SHLS

Shoals Technologies Group Inc.

HOLD

Current Price

$10.12

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$39.25

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHLS
NBTX
Founded
1996
2003
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
SHLS
NBTX
Price
$10.12
$39.25
Analyst Decision
Buy
Strong Buy
Analyst Count
14
1
Target Price
$9.07
$36.00
AVG Volume (30 Days)
5.8M
81.3K
Earning Date
05-05-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
N/A
EPS
N/A
N/A
Revenue
$475,331,000.00
N/A
Revenue This Year
$26.24
$58.17
Revenue Next Year
$11.52
N/A
P/E Ratio
$41.63
N/A
Revenue Growth
19.07
N/A
52 Week Low
$4.44
$4.93
52 Week High
$13.18
$57.14

Technical Indicators

Market Signals
Indicator
SHLS
NBTX
Relative Strength Index (RSI) 50.44 54.43
Support Level $8.10 $38.89
Resistance Level $11.27 $41.89
Average True Range (ATR) 0.82 2.41
MACD -0.03 0.51
Stochastic Oscillator 53.95 62.65

Price Performance

Historical Comparison
SHLS
NBTX

About SHLS Shoals Technologies Group Inc.

Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: